Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 830-832

  Spellberg, Brad ^b   Fu, Yue ^b   Edwards Jr , John E ^b   Ibrahim, Ashraf S ^a  

^a St John's Cardiovascular Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG ANTAGONISM; FUNGUS ISOLATION; MALE; MONOTHERAPY; MOUSE; MUCORMYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RHIZOPUS ORYZAE; SURVIVAL; TREATMENT OUTCOME;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC KETOACIDOSIS; DRUG COMBINATIONS; MALE; MICE; MICE, INBRED BALB C; MUCORMYCOSIS; PEPTIDES, CYCLIC; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; RHIZOPUS; SURVIVAL;

EID: 12944268368     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.830-832.2005     Document Type: Article

References (11)

1. Bowman, J. C., J. W. Anderson, P. A. Liberator, and C. M. Douglas. 2002. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, abstr. M-910, p. 398. American Society for Microbiology, Washington, D.C.
2. Chetchotisakd, P., P. Boonma, M. Sookpranee, and C. Pairojkul. 1991. Rhinocerebral mucormycosis: a report of eleven cases. Southeast Asian J. Trop. Med. Public Health 22:268-273.
3. Cruickshank, G., R. D. Vincent, H. M. Cherrick, and K. Derby. 1977. Rhinocerebral mucormycosis. J. Am. Dental Assoc. 95:1164-1168.
4. Ibrahim, A. S., J. C. Bowman, V. Avanessian, C. M. Douglas, and J. E. Edwards, Jr. 2003. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, abstr. M-371, p. 435. American Society for Microbiology, Washington, D.C.
5. Ibrahim, A. S., V. Avanessian, B. Spellberg, and J. E. Edwards, Jr. 2003. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob. Agents Chemother. 47:3343-3344.
6. Ibrahim, A. S., J. E. J. Edwards, and S. G. Filler. 2003. Zygomycosis, p. 241-251. In W. E. Dismukes, P. G. Pappas, and J. D. Sobel (ed.), Clinical mycology. Oxford University Press, New York, N.Y.
7. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, p. 524-559. Lea & Febiger, Philadelphia, Pa.
8. Ochi, J. W., J. P. Harris, J. I. Feldman, and G. A. Press. 1988. Rhinocerebral mucormycosis: results of aggressive surgical debridement and amphotericin B. Laryngoscope 98:1339-1342.
9. Pagano, L., P. Ricci, A. Tonso, A. Nosari, L. Cudillo, M. Montillo, A. Cenacchi, L. Pacilli, F. Fabbiano, and A. Del Favero. 1997. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br. J. Haematol. 99:331-336.
10. Rhyne, A. L., and R. G. Steel. 1967. A multiple comparisons sign test: all pairs of treatments. Biometrics 23:539-549.
11. Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301.